Article Information
History
- March 18, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Anne-Katrien Stark1,2,*,
- Anita Chandra1,2,3,4,*,
- Krishnendu Chakraborty1,3,
- Rafeah Alam1,
- Valentina Carbonaro1,
- Jonathan Clark5,
- Srividya Sriskantharajah6,
- Glyn Bradley7,
- Alex G. Richter8,9,
- Edward Banham-Hall1,3,4,
- Menna R. Clatworthy10,
- Sergey Nejentsev3,
- J. Nicole Hamblin6,
- Edith M. Hessel6,
- Alison M. Condliffe11 and
- Klaus Okkenhaug1,2,#
- 1Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge CB21 3AT, UK
- 2Division of Immunology, Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK
- 3Department of Medicine, University of Cambridge, CB2 OQQ, UK
- 4Cambridge University Hospitals NHS Trust, Hills Road, Cambridge, CB2 0QQ
- 5Biological Chemistry Laboratory, Babraham Institute, Cambridge CB21 3AT, UK
- 6Refractory Respiratory Inflammation Discovery Performance Unit, Respiratory Therapy Area, GlaxoSmithKline, Stevenage, SG1 2NY, UK
- 7Computational Biology and Statistics, Target Sciences, GlaxoSmithKline, Stevenage, SG1 2NY, UK
- 8Department of Immunology, Queen Elizabeth Hospital, Birmingham, UK
- 9Institute of Immunology and Immunotherapy, University of Birmingham, UK
- 10Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, CB2 OQQ, UK
- 11Department of Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield, Sheffield S10 2RX, UK
- ↵#Correspondence: ko256{at}cam.ac.uk